Fatigue in patients with myasthenia gravis. A systematic review of the literature
Myasthenia Gravis (MG) is a chronic autoimmune disease (AID) with a prevalence of 1 –2 per 10.000 [1]. The clinical hallmark is fluctuating weakness of striated muscles with antibodies directly affecting the neuromuscular junction. In approximately 85% of patients, the initial presenting symptoms are asymmetric ptosis and/or diplopia. Approximately 80% of initially ocular MG pati ents will develop generalized MG within two years of disease onset [2].
Source: Neuromuscular Disorders - Category: Neurology Authors: Annabel M. Ruiter, Jan J.G.M. Verschuuren, Martijn R. Tannemaat Tags: Review Source Type: research